A pragmatic approach to the design and calibration of a Bayesian CRM dose finding trial

被引：0
|
作者：
Michael Cole
Deborah Stocken
Christina Yap
机构：
[1] Newcastle University,
[2] University of Birmingham,undefined
来源：
Trials | / 16卷
关键词：
Public Health; Early Phase; Monte Carlo Simulation; Prior Probability; Specific Requirement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Bayesian dose-finding design for phase I/II clinical trials with nonignorable dropouts
    Guo, Beibei
    Yuan, Ying
    STATISTICS IN MEDICINE, 2015, 34 (10) : 1721 - 1732
  • [42] Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata
    Li, Mo
    Liu, Rachael
    Lin, Jianchang
    Bunn, Veronica
    Zhao, Hongyu
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (05) : 806 - 820
  • [43] Model calibration: A hierarchical Bayesian approach
    Bozorgzadeh, Nezam
    Liu, Zhongqiang
    Nadim, Farrokh
    Lacasse, Suzanne
    PROBABILISTIC ENGINEERING MECHANICS, 2023, 71
  • [44] A Bayesian calibration approach to the thermal problem
    Higdon, Dave
    Nakhleh, Charles
    Gattiker, James
    Williams, Brian
    COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING, 2008, 197 (29-32) : 2431 - 2441
  • [45] A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2
    Guo, Wentian
    Wang, Sue-Jane
    Yang, Shengjie
    Lynn, Henry
    Ji, Yuan
    CONTEMPORARY CLINICAL TRIALS, 2017, 58 : 23 - 33
  • [46] PRAGMATIC APPROACH TO SYSTOLIC DESIGN
    MANOHAR, S
    BAUDET, G
    IEE PROCEEDINGS-E COMPUTERS AND DIGITAL TECHNIQUES, 1990, 137 (04): : 277 - 282
  • [47] A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
    Jin Xu
    Dapeng Zhang
    Rongji Mu
    BMC Medical Research Methodology, 22
  • [48] A Bayesian dose finding design for clinical trials combining a cytotoxic agent with a molecularly targeted agent
    Riviere, M. -K.
    Yuan, Y.
    Dubois, F.
    Zohar, S.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2015, 64 (01) : 215 - 229
  • [49] A Bayesian dose-finding design incorporating toxicity data from multiple treatment cycles
    Yin, Jun
    Qin, Rui
    Ezzalfani, Monia
    Sargent, Daniel J.
    Mandrekar, Sumithra J.
    STATISTICS IN MEDICINE, 2017, 36 (01) : 67 - 80
  • [50] Uniformly most powerful Bayesian interval design for phase I dose-finding trials
    Lin, Ruitao
    Yin, Guosheng
    PHARMACEUTICAL STATISTICS, 2018, 17 (06) : 710 - 724
12345